-
公开(公告)号：US20090252751A1
公开(公告)日：2009-10-08
申请号：US12213947
申请日：2008-06-26
申请人： Shuji Sato , Takeshi Goto , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada
发明人： Shuji Sato , Takeshi Goto , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada
IPC分类号： A61K39/00 , C07C49/603 , A61P31/00
CPC分类号： A61K39/39 , A61K2039/55511 , A61K2039/57 , C07C50/28
摘要： This invention relates to an immunoadjuvant, which has an excellent antibody production enhancing function and is highly safe, and a vaccine composition comprising the immunoadjuvant. More specifically, the present invention relates to an immunoadjuvant comprising a ubiquinone represented by formula (I), and a vaccine composition comprising the ubiquinone represented by formula (I):
摘要翻译： 本发明涉及一种免疫佐剂，其具有优异的抗体产生增强功能并且是高度安全的，以及包含免疫佐剂的疫苗组合物。 更具体地，本发明涉及包含由式（I）表示的泛醌的免疫佐剂和包含由式（I）表示的泛醌的疫苗组合物：
-
2.发明授权公开(公告)号：US09701739B2
公开(公告)日：2017-07-11
申请号：US13817714
申请日：2011-08-19
申请人： Shuji Sato , Takeshi Goto , Shigeru Goto , Toshiaki Nakano , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada , Kenji Mori , Takamitsu Miyagi
发明人： Shuji Sato , Takeshi Goto , Shigeru Goto , Toshiaki Nakano , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada , Kenji Mori , Takamitsu Miyagi
IPC分类号： A61K39/395 , C07K16/18 , C07K7/08
CPC分类号： C07K16/18 , A61K39/39541 , C07K7/08 , C07K2317/34
摘要： The present invention relates to a monoclonal antibody having excellent immunosuppressive activity or an antigen binding fragment thereof. More specifically, the present invention relates to a monoclonal antibody or an antigen binding fragment thereof, which binds to a peptide consisting an amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO: 1) or a conjugate of the peptide and a pharmaceutically acceptable carrier, the monoclonal antibody or an antigen binding fragment thereof having a higher binding affinity for core histone than for histone H1.
-
3.发明申请MONOCLONAL ANTIBODY HAVING IMMUNOSUPPRESSIVE ACTIVITY OR ANTIGEN BINDING FRAGMENT THEREOF 有权具有免疫抑制活性的单克隆抗体或其抗体结合片段公开(公告)号：US20140010815A1
公开(公告)日：2014-01-09
申请号：US13817714
申请日：2011-08-19
申请人： Shuji Sato , Takeshi Goto , Shigeru Goto , Toshiaki Nakano , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada , Kenji Mori , Takamitsu Miyagi
发明人： Shuji Sato , Takeshi Goto , Shigeru Goto , Toshiaki Nakano , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada , Kenji Mori , Takamitsu Miyagi
IPC分类号： C07K16/18
CPC分类号： C07K16/18 , A61K39/39541 , C07K7/08 , C07K2317/34
摘要： The present invention relates to a monoclonal antibody having excellent immunosuppressive activity or an antigen binding fragment thereof. More specifically, the present invention relates to a monoclonal antibody or an antigen binding fragment thereof, which binds to a peptide consisting an amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO: 1) or a conjugate of the peptide and a pharmaceutically acceptable carrier, the monoclonal antibody or an antigen binding fragment thereof having a higher binding affinity for core histone than for histone H1.
摘要翻译： 本发明涉及具有优异免疫抑制活性的单克隆抗体或其抗原结合片段。 更具体地，本发明涉及与由SSVLYGGPPSAA（SEQ ID NO：1）表示的氨基酸序列或肽与药学上可接受的载体的缀合物组成的肽结合的单克隆抗体或其抗原结合片段， 对于核心组蛋白具有比组蛋白H1更高的结合亲和力的单克隆抗体或其抗原结合片段。
-
公开(公告)号：US20120128706A1
公开(公告)日：2012-05-24
申请号：US13316800
申请日：2011-12-12
申请人： Shuji Sato , Takeshi Goto , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada
发明人： Shuji Sato , Takeshi Goto , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada
CPC分类号： A61K39/39 , A61K2039/55511 , A61K2039/57 , A61K2039/6081
摘要： This invention relates to an immunoadjuvant, which has an excellent antibody production enhancing function and is highly safe, and a vaccine composition comprising the immunoadjuvant. More specifically, the present invention relates to an immunoadjuvant comprising ATP or its pharmaceutically acceptable salt, its solvate, or its derivative having a physiological function as an active ingredient, and a vaccine composition comprising the immunoadjuvant.
摘要翻译： 本发明涉及一种免疫佐剂，其具有优异的抗体产生增强功能并且是高度安全的，以及包含免疫佐剂的疫苗组合物。 更具体地，本发明涉及包含具有作为活性成分的生理功能的ATP或其药学上可接受的盐，其溶剂合物或其衍生物的免疫佐剂和包含免疫佐剂的疫苗组合物。
-
公开(公告)号：US20090081247A1
公开(公告)日：2009-03-26
申请号：US12213874
申请日：2008-06-25
申请人： Shuji Sato , Takeshi Goto , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada
发明人： Shuji Sato , Takeshi Goto , Naoya Ohmori , Kueichen Chiang , Yayoi Shimada
CPC分类号： A61K39/39 , A61K2039/55511 , A61K2039/57 , A61K2039/6081
摘要： This invention relates to an immunoadjuvant, which has an excellent antibody production enhancing function and is highly safe, and a vaccine composition comprising the immunoadjuvant. More specifically, the present invention relates to an immunoadjuvant comprising ATP or its pharmaceutically acceptable salt, its solvate, or its derivative having a physiological function as an active ingredient, and a vaccine composition comprising the immunoadjuvant.
摘要翻译： 本发明涉及一种免疫佐剂，其具有优异的抗体产生增强功能并且是高度安全的，以及包含免疫佐剂的疫苗组合物。 更具体地，本发明涉及包含具有作为活性成分的生理功能的ATP或其药学上可接受的盐，其溶剂合物或其衍生物的免疫佐剂和包含免疫佐剂的疫苗组合物。
-
6.发明申请DRUG PRODUCT, A METHOD OF ADMINISTRATING A VACCINE USING THE DRUG PRODUCT, AND AN APPARATUS FOR IONTOPHORESIS 审中-公开药物产品，使用药物产品的疫苗管理方法和用于静脉注射的装置公开(公告)号：US20100324469A1
公开(公告)日：2010-12-23
申请号：US12681508
申请日：2008-10-03
申请人： Kenji Mori , Takamitsu Miyagi , Yayoi Shimada , Kuei-Chen Chiang , Naoya Ohmori , Takeshi Goto , Shuji Sato
发明人： Kenji Mori , Takamitsu Miyagi , Yayoi Shimada , Kuei-Chen Chiang , Naoya Ohmori , Takeshi Goto , Shuji Sato
IPC分类号： A61N1/30
CPC分类号： A61N1/0448 , A61K39/00 , A61K2039/53 , A61K2039/54 , A61N1/0436 , A61N1/0444 , A61N1/30 , A61N1/325
摘要： It is an object of the present invention to provide a method and an apparatus capable of noninvasively administrating vaccine through the skin, and thereby making the immune response activate. A drug product according to the present invention is characterized in that the drug product has a support medium, an electrode formed on the support medium and protected partly by an insulating material for avoiding a direct cutaneous contact, a vaccine containing layer for containing a vaccine, wherein the vaccine is an antigen for inducing an immune suppression protein. A method of administrating a vaccine according to the present invention is characterized in that the vaccine is administrated by the iontophoresis using the drug product according to the drug product of the present invention as an electrode. An apparatus for the iontophoresis according to the present invention is characterized in that the drug product according to the present invention is used as an electrode.
摘要翻译： 本发明的目的是提供一种能够通过皮肤无刺激地施用疫苗，从而使免疫反应活化的方法和装置。 根据本发明的药物产品的特征在于药物产品具有载体介质，形成在载体介质上的电极，部分地被绝缘材料保护以避免直接皮肤接触，含有疫苗的疫苗含有层， 其中所述疫苗是用于诱导免疫抑制蛋白的抗原。 本发明疫苗的施用方法的特征在于，使用本发明药物的药物作为电极，通过离子电渗法给予疫苗。 本发明的离子电渗疗法的特征在于，将本发明的药物用作电极。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.021 秒)
